Research and Markets: Brazilian Generic Industry Guide

The Brazilian pharma market is growing rapidly into one of the largest pharma markets in the world. Unbranded and branded generics are among the fastest growing segments within this market.

Java Training Courses

For 2012, IMS monetary values for the prescription market were around 26 billion dollars, with unbranded and branded generics representing an approximate combined 40% share, and over 1.2 billion manufacturing units with unbranded and branded generics representing a combined 50% share, showing a growing trend.

Industry Trends

For unbranded generics alone, the market counts on 400 different actives spread over 4000 individual registration approvals with approx. 18,000 different presentations, with solid perspectives of continued strong growth.

Ever since the genesis of the Brazilian unbranded generics segment in 2000, the interest of international suppliers and manufacturers of non-patented formulations in the Brazilian market has grown steadily and significantly. However, as they start to deal with the local business and institutional culture, most of these companies face serious and unexpected difficulties.

Key Topics Covered:

1) Brief Introduction & Background

2) types of registrations for Medicines

3) regulatory requirements

- GMP Requirements

Read More: heraldonline.com